Company Filing History:
Years Active: 2009
Title: John B Halstrøm: Innovator in Peptide Derivatives
Introduction
John B Halstrøm is a notable inventor based in Hundested, Denmark. He has made significant contributions to the field of pharmacology through his innovative work on peptide derivatives. His research focuses on modifying peptide hormones to enhance their pharmacological properties.
Latest Patents
John B Halstrøm holds 1 patent for his invention related to peptide derivatives. This patent describes a pharmacologically active peptide hormone derivative in which the parent peptide hormone has been modified. The modification involves introducing either a lipophilic substituent, W, in the N-terminal amino acid or a lipophilic substituent, Z, in the C-terminal amino acid of the parent peptide hormone. These lipophilic substituents contain between 8 to 40 carbon atoms and result in a protracted profile of action.
Career Highlights
Halstrøm is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. His work at Novo Nordisk has allowed him to contribute to advancements in therapeutic solutions.
Collaborations
Throughout his career, John B Halstrøm has collaborated with esteemed colleagues such as Ib Jonassen and Svend Havelund. These collaborations have further enriched his research and development efforts in the field of peptide derivatives.
Conclusion
John B Halstrøm's innovative work in peptide derivatives exemplifies the impact of scientific research on pharmacology. His contributions continue to influence the development of effective therapeutic agents.